Worksol Group CEO Urges Strategic Labor Policy During EEC 2025 in Katowice
Katowice, Poland--(Newsfile Corp. - July 1, 2025) - At the prestigious European Economic Congress (EEC) held in Katowice, Michael Solecki, CEO of Worksol Group, addressed a packed auditorium of policymakers and business leaders, calling for a comprehensive national strategy on the employment of foreign workers. As a keynote speaker, Solecki emphasized the urgent need for Poland to adopt a long-term vision for labor migration, ensuring sustained economic growth amid evolving demographic and market challenges.
"Poland is at a crossroads," said Solecki during his panel at the EEC. "We must decide whether we want to be merely a transit country for foreign workers-or a long-term destination. Without a forward-thinking policy, we risk losing the competitive advantage we've worked so hard to build."
A pioneering role in cross-border staffing
Headquartered in Kępno, Poland (Warszawska 32 St.), Worksol Group has built its reputation by specializing in the recruitment and legal employment of workers from countries as diverse as Colombia, Indonesia, the Philippines, Ukraine, Uzbekistan, Japan, UAE and beyond. With a strong focus on ethical recruitment, compliance, and operational transparency, Worksol has helped companies across Poland and Europe meet critical labor shortages in sectors like manufacturing, agriculture, and logistics.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8871/257064_real_9e575fe6-fa25-4bf7-8055-ce9fd1f6dd11.jpg
"At Worksol, we don't just fill vacancies. We create sustainable partnerships between businesses and people from around the world," added Solecki.
The company's approach aligns closely with the European Union's emphasis on fair labor mobility, positioning Poland not only as a growing economic force but also as a strategic labor corridor between East and West.
A call to action for policymakers
During his EEC appearance, Solecki underlined the pressing need for regulatory stability and institutional cooperation in the employment of third-country nationals. The call resonated strongly with the audience, especially amid ongoing debate within the EU on how to balance labor demand with integration and social cohesion.
Worksol Group's presence at the EEC symbolizes more than business success-it highlights Poland's emerging role as a case study in post-transition economic resilience and innovation in workforce solutions.
About Worksol Group
Founded in Poland, Worksol Group is a premier temporary staffing and recruitment agency offering cross-border employment services across Europe. The company has helped hundreds of employers meet their workforce needs while facilitating ethical and legal migration for skilled and semi-skilled workers from outside the European Union.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 days ago
- Globe and Mail
Femasys Revenue Jumps 85 Percent in Q2
Key Points Revenue surged 84.8% to $0.41 million (GAAP) in Q2 2025, far outpacing consensus estimates (GAAP) but still early-stage in scale. FemBloc gained its first-ever European approval; FemaSeed and FemVue secured new regulatory clearances and partnerships. Net loss (GAAP) narrowed slightly to $4.59 million, while cash reserves (GAAP) dropped to $3.22 million, bringing a near-term cash crunch. These 10 stocks could mint the next wave of millionaires › Femasys (NASDAQ:FEMY), a women's health medical technology firm developing permanent birth control and fertility solutions, released its second quarter 2025 results on August 8, 2025. The earnings report was marked by strong revenue growth to $0.41 million (GAAP)—an 84.8% jump in GAAP sales from the prior year period—driven by accelerating early-stage sales of FemaSeed intratubal insemination devices and FemVue diagnostic systems. This figure (GAAP revenue of $409,268) came in far above analyst estimates. The company posted a GAAP net loss of $4.59 million, a slight improvement from the $4.68 million GAAP net loss in Q2 2024. Diluted earnings per share (GAAP) was slightly better than analyst estimates at $(0.16). Despite clear commercial and regulatory progress, continued operating losses and a $3.22 million cash balance as of June 30, 2025 mean Femasys will need additional funding within the next quarter to sustain operations. Source: Analyst estimates for the quarter provided by FactSet. Femasys at a Glance and Business Focus Femasys designs and commercializes non-surgical products for women's reproductive health needs. Its main portfolio spans permanent birth control devices—most notably the FemBloc system—and fertility-related solutions like FemaSeed and FemVue. Recent company focus has been on winning new regulatory approvals, especially for FemBloc, and moving early-stage products from research and development into wider commercial sales. Key success factors for Femasys include clearing regulatory hurdles in each market, gaining adoption from clinics and patients, and forming the right distribution partnerships. Protecting its intellectual property is also essential given the specialized nature of its technology. Quarter Highlights: Financial and Product Progress Revenue (GAAP) climbed 84.8%, driven by sales of FemaSeed and FemVue. A roughly $400,000 order from Spain signals a pivotal step in international expansion efforts. Sales of FemaSeed intratubal insemination devices and FemVue diagnostic products—tools that facilitate fertility assessment—drove most of the top-line gain. Together, these products represent the company's early moves beyond the U.S. market. On the regulatory front, Femasys achieved a series of important clearances: FemBloc received its first European approval, marking the first global regulatory sign-off for a non-surgical permanent birth control option in the company's portfolio. FemaSeed and FemVue also gained approvals in Australia and New Zealand, expanding potential markets and laying groundwork for future sales. Ongoing enrollment in U.S. pivotal trials for FemBloc continues, which will be crucial for future coverage and adoption in the American healthcare market. The company expanded its reach through new partnerships. It announced a relationship with the Carolinas Fertility Institute, an eight-clinic network in the U.S, to offer FemaSeed to more patients. Distribution partnerships in Spain will support further commercialization of FemBloc. Femasys also shored up its patent portfolio, receiving notice of intent to grant new patents in Europe and the U.S. for FemBloc and FemaSeed, maintaining its lead in the emerging non-surgical device category. Financially, the net loss (GAAP) narrowed slightly to $4.59 million, reflecting both increased sales and a 28.4% drop in research and development expense as products transition to the commercial phase. However, cash burn remained high: the $3.22 million cash balance at June 30, 2025 gives the company only enough runway to operate into early fourth quarter, without additional funding. The company raised $4.5 million in new equity but continued operating losses have quickly reduced available resources. Inventory increased 71.8% year-to-date (as of June 30, 2025), showing strategic preparation for expected sales but also a concentration of capital in unsold goods. The share count rose from 23,355,926 as of December 31, 2024, to 32,575,407 as of June 30, 2025. Femasys does not currently pay a dividend. Looking Forward Femasys management did not provide specific revenue or earnings targets for the coming quarters or for fiscal 2025. Leadership emphasized that the next stages will focus on translating recent approvals and pilot orders into routine commercial adoption, particularly in the European Union and new Asia-Pacific markets, and continuing to build distribution and clinic partnerships. Given the current cash position as of June 30, 2025, the company expects its cash and cash equivalents will be sufficient to fund operations into the early fourth quarter of 2025. The expanding international footprint and product pipeline, along with progress on intellectual property protection, remain important areas for investors to monitor in the coming periods. FEMY does not currently pay a dividend. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,047%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 4, 2025
Globe and Mail
2 days ago
- Globe and Mail
Energica Motorcycles Rescued by Singaporean Investors in Surprise Move
Modena, Italy--(Newsfile Corp. - August 8, 2025) - In a surprising yet promising development for the electric vehicle industry, renowned Italian electric motorcycle manufacturer Energica Motor Company has been acquired by a group of Singaporean investors. The acquisition follows a judicial sale process and signals a renewed vision for the future of the high-performance electric motorcycle brand. Energica Motorcycles To view an enhanced version of this graphic, please visit: The new investors, whose identities have not yet been publicly disclosed, are said to be passionate followers of the Energica legacy and are committed to restoring the company's position in the global electric mobility market. The move has been welcomed by industry observers and brand loyalists alike, who see the acquisition as a lifeline for a company known for innovation, engineering excellence, and sustainable performance. In a recent video update, Energica's leadership confirmed that the current management team will remain in place under the new ownership. This decision is intended to ensure operational continuity, protect the brand's long-standing engineering ethos, and keep development of its next-generation electric motorcycles on track. "We're thrilled to retain the same passionate team that helped make Energica a recognized name in electric performance motorcycles," the company shared. "This transition isn't the end of the road - it's a fresh start. We remain fully committed to our customers, our community, and the mission to lead the future of electric mobility." Energica Motorcycles To view an enhanced version of this graphic, please visit: The judicial sale process, a form of legal restructuring, is expected to be finalized within the next 60 days. During this period, the company will begin implementing strategic steps to stabilize and strengthen its operations. According to insiders, Energica will prioritize rebuilding relationships with distributors and commercial partners, reestablishing supply chain consistency, and reinforcing customer support channels. The new ownership group is also expected to inject fresh capital and potentially expand the company's reach in key global markets, particularly in Asia, where demand for high-end electric two-wheelers is rising. Energica, based in Modena - a region globally revered for Italian automotive craftsmanship - is known for producing premium electric motorcycles that combine speed, sustainability, and cutting-edge technology. With this acquisition, the company appears poised to regain its momentum and play a significant role in the next era of electric transportation. About Energica Motor Company Energica is an Italian manufacturer of high-performance electric motorcycles. The company has built a global reputation for producing sustainable, technologically advanced two-wheelers that offer both exhilarating performance and environmental responsibility. Visit:
Globe and Mail
2 days ago
- Globe and Mail
D-Wave Quantum (NYSE: QBTS): 27% of Surveyed Business Leaders Expect $5M+ ROI from Quantum Optimization Within First Year
Survey by Wakefield Research and D-Wave shows 46% of surveyed business leaders expect $1 million to $5 million ROI from quantum optimization within the first year of adoption. 81% believe they have reached the limits of classical computing's capabilities for optimization. 53% are planning to integrate quantum computing into their workflows, while 27% are considering it. Quantum optimization is seen as especially valuable in logistics, supply chain, manufacturing, planning and inventory, and R&D. 88% of participants said their organizations would 'go above and beyond' for even a 5% improvement in optimization. A new survey released by D-Wave Quantum Inc. (NYSE: QBTS) ('D-Wave'), a leader in quantum computing systems, software, and services, suggests that quantum computing is gaining traction as a business tool, particularly for optimization problems. The findings point to a growing belief among surveyed decision-makers that classical computing may no longer be sufficient for the operational challenges they face ( Conducted by Wakefield Research, the survey queried 400 business leaders from North America, Europe, and the Asia-Pacific region in May 2025. Respondents were decision-makers from industries such as logistics, manufacturing, life sciences, financial services, and retail; sectors where optimization is central… Read More>> About D-Wave Quantum Inc. D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world's first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our quantum computers, the world's largest, are available on-premises or via the cloud, supported by 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our quantum systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we're shaping the quantum-driven industrial and societal advancements of tomorrow: Forward Looking Statements Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading 'Risk Factors' discussed under the caption 'Item 1A. Risk Factors' in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption 'Item 1A. Risk Factors' in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: Corporate Communications
